Reducing alcohol consumption, quitting smoking, and managing other conditions like diabetes and high cholesterol can also help improve liver health
Bowel Obstruction Injuries from GLP-1 Drugs Explained GLP-1 receptor agonists are prescribed to help manage diabetes and support weight loss, but they are now under investigation following reports of serious gastrointestinal injuries
Contact the Rebecca at 276-235-3205 or [email protected] Research References: Abdulghani, AA, Sherr S, Shirin S, Solodkina G, Tapia EM, Gottlieb AB
Some of the major market players in the GLP-1 receptor agonist industry include Amgen Inc., Eli Lilly and Company, Hanmi Pharm Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novo Nordisk A/S, Paige Biomedicine (Suzhou) Co., Ltd., and Sanofi S.A
Among those 65 and older, use of GLP-1 agonists is somewhat higher for men than for women